"10.1371_journal.pone.0035083","plos one","2012-04-11T00:00:00Z","Rachel P J Lai; Michael S Seaman; Paul Tonks; Frank Wegmann; David J Seilly; Simon D W Frost; Celia C LaBranche; David C Montefiori; Antu K Dey; Indresh K Srivastava; Quentin Sattentau; Susan W Barnett; Jonathan L Heeney","Department of Veterinary Medicine, University of Cambridge, Cambridge, United Kingdom; Division of Viral Pathogenesis, Beth Israel Deaconess Medical Center, Boston, Massachusetts, United States of America; The Sir William Dunn School of Pathology, University of Oxford, Oxford, United Kingdom; Department of Surgery, Duke University Medical Center, Durham, North Carolina, United States of America; Novartis Vaccines and Diagnostics Inc., Massachusetts, United States of America","Conceived and designed the experiments: RPJL IKS QS SWB JLH. Performed the experiments: RPJL PT FW DJS AKD. Analyzed the data: RPJL MSS SDWF CCL DCM. Contributed reagents/materials/analysis tools: MSS SDWF CCL DCM AKD IKS QS SWB. Wrote the paper: RPJL JLH.","AKD and SWB are employees at Novartis Vaccines & Diagnostics (NVD). SWB is a shareholder of NVD. MF59 is a patented adjuvant of NVD. This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials.","2012","04","Rachel P J Lai","RPJL",13,TRUE,5,5,5,2,TRUE,TRUE,FALSE,0,NA,FALSE
